This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nolte, F. S.
Right arrow Articles by Lennox, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nolte, F. S.
Right arrow Articles by Lennox, J. L.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 1998, p. 716-720, Vol. 36, No. 3
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Clinical Comparison of an Enhanced-Sensitivity Branched-DNA Assay and Reverse Transcription-PCR for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma

Frederick S. Nolte,1,2,* Jodi Boysza,1 Cathy Thurmond,1 W. Scott Clark,3 and Jeffrey L. Lennox2

Departments of Pathology and Laboratory Medicine1 and Medicine,2 Emory University School of Medicine, and Department of Biostatistics, Emory University School of Public Health,3 Atlanta, Georgia 30322

Received 25 July 1997/Returned for modification 1 October 1997/Accepted 25 November 1997

The performance characteristics of an enhanced-sensitivity branched-DNA assay (bDNA) (Quantiplex HIV-1 version 2.0; Chiron Corp., Emeryville, Calif.) and a reverse transcription (RT)-PCR assay (AMPLICOR HIV-1 Monitor; Roche Diagnostic Systems, Inc., Branchburg, N.J.) were compared in a molecular diagnostic laboratory. Samples used in this evaluation included linearity and reproducibility panels made by dilution of a human immunodeficiency virus type 1 (HIV-1) stock culture of known virus particle count in HIV-1-negative plasma, a subtype panel consisting of HIV-1 subtypes A through F at a standardized level, and 64 baseline plasma specimens from HIV-1-infected individuals. Plots of log10 HIV RNA copies per milliliter versus log10 nominal virus particles per milliliter demonstrated that both assays were linear over the stated dynamic ranges (bDNA, r = 0.98; RT-PCR, r = 0.99), but comparison of the slopes of the regression lines (bDNA, m = 0.96; RT-PCR, m = 0.83) suggested that RT-PCR had greater proportional systematic error. The between-run coefficients of variation for bDNA and RT-PCR were 24.3 and 34.3%, respectively, for a sample containing 1,650 nominal virus particles/ml and 44.0 and 42.7%, respectively, for a sample containing 165 nominal virus particles/ml. Subtypes B, C, and D were quantitated with similar efficiencies by bDNA and RT-PCR; however, RT-PCR was less efficient in quantitating subtypes A, E, and F. One non-B subtype was recognized in our clinical specimens based on the ratio of values obtained with the two methods. HIV-1 RNA was quantitated in 53 (83%) baseline plasma specimens by bDNA and in 55 (86%) specimens by RT-PCR. RT-PCR values were consistently greater than bDNA values, with population means of 142,419 and 67,580 copies/ml, respectively (P < 0.01). The results were highly correlated (r = 0.91), but the agreement was poor (mean difference in log10 copies per milliliter ± 2 standard deviations, 0.45 ± 0.61) for the 50 clinical specimens that gave discrete values with both methods.


* Corresponding author. Mailing address: Emory University Hospital, Clinical Laboratories, Room F145, 1364 Clifton Rd., NE, Atlanta, GA 30322. Phone: (404) 712-7297. Fax: (404) 712-5567. E-mail: fnolte{at}emory.edu


Journal of Clinical Microbiology, March 1998, p. 716-720, Vol. 36, No. 3
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Hill, C. E., Green, A. M., Ingersoll, J., Easley, K. A., Nolte, F. S., Caliendo, A. M. (2004). Assessment of Agreement between the AMPLICOR HIV-1 MONITOR Test Versions 1.0 and 1.5. J. Clin. Microbiol. 42: 286-289 [Abstract] [Full Text]  
  • Treadwell, T. L, Fleisher, J. (2003). Underestimation of HIV-1 Plasma Viral Burden in Patients Who Acquire Infection Abroad: The Experience in a Community Hospital Clinic. Arch Intern Med 163: 1613-1614 [Abstract] [Full Text]  
  • Jaye, D. L., Nolte, F. S., Mazzucchelli, L., Geigerman, C., Akyildiz, A., Parkos, C. A. (2003). Use of Real-Time Polymerase Chain Reaction to Identify Cell- and Tissue-Type-Selective Peptides by Phage Display. Am. J. Pathol. 162: 1419-1429 [Abstract] [Full Text]  
  • Giachetti, C., Linnen, J. M., Kolk, D. P., Dockter, J., Gillotte-Taylor, K., Park, M., Ho-Sing-Loy, M., McCormick, M. K., Mimms, L. T., McDonough, S. H. (2002). Highly Sensitive Multiplex Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA. J. Clin. Microbiol. 40: 2408-2419 [Abstract] [Full Text]  
  • Kellogg, J. A., Atria, P. V., Sanders, J. C., Eyster, M. E. (2001). Intra- and Interlaboratory Variabilities of Results Obtained with the Quantiplex Human Immunodeficiency Virus Type 1 RNA bDNA Assay, Version 3.0. CVI 8: 560-563 [Abstract] [Full Text]  
  • de Baar, M. P., Timmermans, E. C., Bakker, M., de Rooij, E., van Gemen, B., Goudsmit, J. (2001). One-Tube Real-Time Isothermal Amplification Assay To Identify and Distinguish Human Immunodeficiency Virus Type 1 Subtypes A, B, and C and Circulating Recombinant Forms AE and AG. J. Clin. Microbiol. 39: 1895-1902 [Abstract] [Full Text]  
  • Murphy, D. G., Côté, L., Fauvel, M., René, P., Vincelette, J. (2000). Multicenter Comparison of Roche COBAS AMPLICOR MONITOR Version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex Version 3.0 for Quantification of Human Immunodeficiency Virus Type 1 RNA in Plasma. J. Clin. Microbiol. 38: 4034-4041 [Abstract] [Full Text]  
  • Zanchetta, N., Nardi, G., Tocalli, L., Drago, L., Bossi, C., Pulvirenti, F. R., Galli, C., Gismondo, M. R. (2000). Evaluation of the Abbott LCx HIV-1 RNA Quantitative, a New Assay for Quantitative Determination of Human Immunodeficiency Virus Type 1 RNA. J. Clin. Microbiol. 38: 3882-3886 [Abstract] [Full Text]  
  • Louie, M., Louie, L., Simor, A. E. (2000). The role of DNA amplification technology in the diagnosis of infectious diseases. CMAJ 163: 301-309 [Abstract] [Full Text]  
  • Emery, S., Bodrug, S., Richardson, B. A., Giachetti, C., Bott, M. A., Panteleeff, D., Jagodzinski, L. L., Michael, N. L., Nduati, R., Bwayo, J., Kreiss, J. K., Overbaugh, J. (2000). Evaluation of Performance of the Gen-Probe Human Immunodeficiency Virus Type 1 Viral Load Assay Using Primary Subtype A, C, and D Isolates from Kenya. J. Clin. Microbiol. 38: 2688-2695 [Abstract] [Full Text]  
  • Elbeik, T., Charlebois, E., Nassos, P., Kahn, J., Hecht, F. M., Yajko, D., Ng, V., Hadley, K. (2000). Quantitative and Cost Comparison of Ultrasensitive Human Immunodeficiency Virus Type 1 RNA Viral Load Assays: Bayer bDNA Quantiplex Versions 3.0 and 2.0 and Roche PCR Amplicor Monitor Version 1.5. J. Clin. Microbiol. 38: 1113-1120 [Abstract] [Full Text]  
  • Jagodzinski, L. L., Wiggins, D. L., McManis, J. L., Emery, S., Overbaugh, J., Robb, M., Bodrug, S., Michael, N. L. (2000). Use of Calibrated Viral Load Standards for Group M Subtypes of Human Immunodeficiency Virus Type 1 To Assess the Performance of Viral RNA Quantitation Tests. J. Clin. Microbiol. 38: 1247-1249 [Abstract] [Full Text]  
  • Manegold, C., Krempe, C., Jablonowski, H., Kajala, L., Dietrich, M., Adams, O. (2000). Comparative Evaluation of Two Branched-DNA Human Immunodeficiency Virus Type 1 RNA Quantification Assays with Lower Detection Limits of 50 and 500 Copies per Milliliter. J. Clin. Microbiol. 38: 914-917 [Abstract] [Full Text]  
  • Highbarger, H. C., Alvord, W. G., Jiang, M. K., Shah, A. S., Metcalf, J. A., Lane, H. C., Dewar, R. L. (1999). Comparison of the Quantiplex Version 3.0 Assay and a Sensitized Amplicor Monitor Assay for Measurement of Human Immunodeficiency Virus Type 1 RNA Levels in Plasma Samples. J. Clin. Microbiol. 37: 3612-3614 [Abstract] [Full Text]  
  • Brodine, S. K., Shaffer, R. A., Starkey, M. J., Tasker, S. A., Gilcrest, J. L., Louder, M. K., Barile, A., VanCott, T. C., Vahey, M. T., McCutchan, F. E., Birx, D. L., Richman, D. D., Mascola, J. R. (1999). Drug Resistance Patterns, Genetic Subtypes, Clinical Features, and Risk Factors in Military Personnel with HIV-1 Seroconversion. ANN INTERN MED 131: 502-506 [Abstract] [Full Text]  
  • Michael, N. L., Herman, S. A., Kwok, S., Dreyer, K., Wang, J., Christopherson, C., Spadoro, J. P., Young, K. K. Y., Polonis, V., McCutchan, F. E., Carr, J., Mascola, J. R., Jagodzinski, L. L., Robb, M. L. (1999). Development of Calibrated Viral Load Standards for Group M Subtypes of Human Immunodeficiency Virus Type 1 and Performance of an Improved AMPLICOR HIV-1 MONITOR Test with Isolates of Diverse Subtypes. J. Clin. Microbiol. 37: 2557-2563 [Abstract] [Full Text]  
  • de Baar, M. P., van der Schoot, A. M., Goudsmit, J., Jacobs, F., Ehren, R., van der Horn, K. H. M., Oudshoorn, P., de Wolf, F., de Ronde, A. (1999). Design and Evaluation of a Human Immunodeficiency Virus Type 1 RNA Assay Using Nucleic Acid Sequence-Based Amplification Technology Able To Quantify Both Group M and O Viruses by Using the Long Terminal Repeat as Target. J. Clin. Microbiol. 37: 1813-1818 [Abstract] [Full Text]  
  • Erali, M., Hillyard, D. R. (1999). Evaluation of the Ultrasensitive Roche Amplicor HIV-1 Monitor Assay for Quantitation of Human Immunodeficiency Virus Type 1 RNA. J. Clin. Microbiol. 37: 792-795 [Abstract] [Full Text]  
  • Segondy, M., Izopet, J., Pellegrin, I., Montes, B., Dumon, B., Pasquier, C., Peeters, M., Fleury, H. J. A., Puel, J., Reynes, J. (1998). Comparison of the QUANTIPLEX HIV-1 RNA 2.0 Assay with the AMPLICOR HIV-1 MONITOR 1.0 Assay for Quantitation of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma of Patients Receiving Stavudine-Didanosine Combination Therapy. J. Clin. Microbiol. 36: 3392-3395 [Abstract] [Full Text]